Feb 26, 2026 08:13AM

Feb 19, 2026 04:15PM

Feb 10, 2026 06:55AM

Feb 9, 2026 08:00AM

Feb 6, 2026 08:02AM

Feb 6, 2026 07:57AM

Jan 22, 2026 09:25AM Polyrizon begins usability study for NASARIX allergy blocker

Jan 13, 2026 08:39AM

Jan 8, 2026 08:46AM

Jan 5, 2026 09:07AM

Jan 2, 2026 08:32AM

Dec 29, 2025 07:20AM

Dec 11, 2025 08:16AM

Dec 8, 2025 08:56AM Polyrizon completes FDA pre-submission meeting for PL-14 nasal spray

Dec 3, 2025 09:29AM

Dec 2, 2025 07:55AM

Nov 7, 2025 04:18PM

Nov 6, 2025 08:55AM

Oct 6, 2025 08:21AM

Sep 19, 2025 08:15AM

Sep 12, 2025 07:26AM Polyrizon reports successful nasal delivery of allergy blocker in study

Jul 22, 2025 08:32AM

Jul 15, 2025 07:55AM

Jun 12, 2025 07:32AM

May 23, 2025 04:17PM

May 13, 2025 07:45AM

Apr 25, 2025 07:37AM

Apr 2, 2025 09:06AM Polyrizon (PLRZ) Engages Leading Branding Firm for Strategic Brand Development

Apr 1, 2025 04:09PM

Mar 31, 2025 09:33AM

Mar 27, 2025 08:25AM

Mar 25, 2025 04:04PM

Mar 19, 2025 07:37AM

Mar 14, 2025 08:36AM

Mar 13, 2025 07:51AM Polyrizon (PLRZ) Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform

Mar 10, 2025 07:48AM

Jan 30, 2025 05:57AM

Dec 30, 2024 04:56PM

Dec 19, 2024 07:23AM

Dec 13, 2024 06:26AM

Oct 30, 2024 01:50PM

Oct 29, 2024 05:59AM Polyrizon (PLRZ) Prices 958.9K Share IPO at $4.38/unit

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All